Do analysts rate HBIO or BFRG?

Harvard Bioscience presently has a consensus price target of $6.75, indicating a potential downside of 16.77%. Given Harvard Bioscience's stronger consensus rating and higher probable upside, analysts plainly believe Harvard Bioscience is more favorable than Bullfrog AI. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Harvard Bioscience 1 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 Bullfrog AI 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50

Do analysts recommend BFRG or BNGO?

Bionano Genomics has a consensus price target of $6.00, suggesting a potential upside of 391.80%. Given Bionano Genomics' stronger consensus rating and higher possible upside, analysts plainly believe Bionano Genomics is more favorable than Bullfrog AI. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Bullfrog AI 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50 Bionano Genomics 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00

Is BFRG or BNGO more profitable?

Bullfrog AI has a net margin of 0.00% compared to Bionano Genomics' net margin of -106.58%. Bionano Genomics' return on equity of -78.78% beat Bullfrog AI's return on equity. Company Net Margins Return on Equity Return on Assets Bullfrog AI N/A -150.36% -127.98% Bionano Genomics -106.58% -78.78% -48.54%

Do analysts prefer BFRG or VIVS?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Bullfrog AI 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50 VivoSim Labs 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Is BFRG or VIVS more profitable?

Bullfrog AI has a net margin of 0.00% compared to VivoSim Labs' net margin of -11,016.07%. Bullfrog AI's return on equity of -150.36% beat VivoSim Labs' return on equity. Company Net Margins Return on Equity Return on Assets Bullfrog AI N/A -150.36% -127.98% VivoSim Labs -11,016.07% -612.23% -177.02%

Do analysts rate BFRG or ISPC?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Bullfrog AI 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50 iSpecimen 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Is BFRG or ISPC more profitable?

Bullfrog AI has a net margin of 0.00% compared to iSpecimen's net margin of -2,445.40%. Bullfrog AI's return on equity of -150.36% beat iSpecimen's return on equity. Company Net Margins Return on Equity Return on Assets Bullfrog AI N/A -150.36% -127.98% iSpecimen -2,445.40% -524.39% -140.42%

Do analysts recommend BFRG or TBIO?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Bullfrog AI 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50 Telesis Bio 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Is BFRG or TBIO more profitable?

Bullfrog AI has a net margin of 0.00% compared to Telesis Bio's net margin of -336.59%. Telesis Bio's return on equity of 0.00% beat Bullfrog AI's return on equity. Company Net Margins Return on Equity Return on Assets Bullfrog AI N/A -150.36% -127.98% Telesis Bio -336.59% N/A -61.89%

Bullfrog AI (BFRG) Competitors

$0.54 -0.01 (-0.93%)

Closing price 08/31/2026 04:00 PM Eastern

Extended Trading

$0.55 +0.02 (+3.53%)

As of 04:33 AM Eastern

Compare

BFRG vs. HBIO, BNGO, VIVS, ISPC, and TBIO

Should you buy Bullfrog AI stock or one of its competitors? Bullfrog AI's main competitors and comparable companies include Harvard Bioscience (HBIO), Bionano Genomics (BNGO), VivoSim Labs (VIVS), iSpecimen (ISPC), and Telesis Bio (TBIO). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "life sciences tools & services" industry.

How does Bullfrog AI compare to Harvard Bioscience?

Harvard Bioscience (NASDAQ:HBIO) and Bullfrog AI (NASDAQ:BFRG) are both small-cap healthcare companies, but which is the superior investment? We will contrast the two businesses based on the strength of their earnings, valuation, institutional ownership, risk, profitability, dividends, analyst recommendations and media sentiment.

In the previous week, Harvard Bioscience and Harvard Bioscience both had 1 articles in the media. Harvard Bioscience's average media sentiment score of 1.89 beat Bullfrog AI's score of 0.93 indicating that Harvard Bioscience is being referred to more favorably in the media.

Company	Overall Sentiment
Harvard Bioscience	Very Positive
Bullfrog AI	Positive

Harvard Bioscience has a beta of 1.49, suggesting that its stock price is 49% more volatile than the broader market. Comparatively, Bullfrog AI has a beta of -2.7, suggesting that its stock price is 370% less volatile than the broader market.

Harvard Bioscience presently has a consensus price target of $6.75, indicating a potential downside of 16.77%. Given Harvard Bioscience's stronger consensus rating and higher probable upside, analysts plainly believe Harvard Bioscience is more favorable than Bullfrog AI.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Harvard Bioscience	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Bullfrog AI	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50

Bullfrog AI has lower revenue, but higher earnings than Harvard Bioscience. Harvard Bioscience is trading at a lower price-to-earnings ratio than Bullfrog AI, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Harvard Bioscience	$86.55M	0.43	-$56.70M	-$2.31	N/A
Bullfrog AI	$120K	82.67	-$6.50M	-$0.46	N/A

Bullfrog AI has a net margin of 0.00% compared to Harvard Bioscience's net margin of -11.86%. Harvard Bioscience's return on equity of -33.13% beat Bullfrog AI's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Harvard Bioscience	-11.86%	-33.13%	-4.80%
Bullfrog AI	N/A	-150.36%	-127.98%

80.9% of Harvard Bioscience shares are owned by institutional investors. Comparatively, 1.0% of Bullfrog AI shares are owned by institutional investors. 17.0% of Harvard Bioscience shares are owned by insiders. Comparatively, 14.7% of Bullfrog AI shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Summary

Harvard Bioscience beats Bullfrog AI on 10 of the 15 factors compared between the two stocks.

How does Bullfrog AI compare to Bionano Genomics?

Bullfrog AI (NASDAQ:BFRG) and Bionano Genomics (NASDAQ:BNGO) are both small-cap healthcare companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, profitability, earnings, risk, media sentiment, valuation, dividends and analyst recommendations.

1.0% of Bullfrog AI shares are held by institutional investors. Comparatively, 11.4% of Bionano Genomics shares are held by institutional investors. 14.7% of Bullfrog AI shares are held by insiders. Comparatively, 0.7% of Bionano Genomics shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

In the previous week, Bullfrog AI and Bullfrog AI both had 1 articles in the media. Bionano Genomics' average media sentiment score of 0.94 beat Bullfrog AI's score of 0.93 indicating that Bionano Genomics is being referred to more favorably in the news media.

Company	Overall Sentiment
Bullfrog AI	Positive
Bionano Genomics	Positive

Bionano Genomics has a consensus price target of $6.00, suggesting a potential upside of 391.80%. Given Bionano Genomics' stronger consensus rating and higher possible upside, analysts plainly believe Bionano Genomics is more favorable than Bullfrog AI.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Bullfrog AI	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50
Bionano Genomics	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Bullfrog AI has a beta of -2.7, suggesting that its stock price is 370% less volatile than the broader market. Comparatively, Bionano Genomics has a beta of 1.63, suggesting that its stock price is 63% more volatile than the broader market.

Bullfrog AI has higher earnings, but lower revenue than Bionano Genomics. Bullfrog AI is trading at a lower price-to-earnings ratio than Bionano Genomics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Bullfrog AI	$120K	82.67	-$6.50M	-$0.46	N/A
Bionano Genomics	$28.51M	0.50	-$26.40M	-$3.02	N/A

Bullfrog AI has a net margin of 0.00% compared to Bionano Genomics' net margin of -106.58%. Bionano Genomics' return on equity of -78.78% beat Bullfrog AI's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Bullfrog AI	N/A	-150.36%	-127.98%
Bionano Genomics	-106.58%	-78.78%	-48.54%

Summary

Bionano Genomics beats Bullfrog AI on 10 of the 15 factors compared between the two stocks.

How does Bullfrog AI compare to VivoSim Labs?

Bullfrog AI (NASDAQ:BFRG) and VivoSim Labs (NASDAQ:VIVS) are both small-cap healthcare companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, valuation, institutional ownership, analyst recommendations, earnings, risk, profitability and media sentiment.

Bullfrog AI has higher earnings, but lower revenue than VivoSim Labs. Bullfrog AI is trading at a lower price-to-earnings ratio than VivoSim Labs, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Bullfrog AI	$120K	82.67	-$6.50M	-$0.46	N/A
VivoSim Labs	$130K	37.19	-$13.84M	-$4.47	N/A

1.0% of Bullfrog AI shares are owned by institutional investors. Comparatively, 8.2% of VivoSim Labs shares are owned by institutional investors. 14.7% of Bullfrog AI shares are owned by insiders. Comparatively, 1.0% of VivoSim Labs shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

In the previous week, Bullfrog AI and Bullfrog AI both had 1 articles in the media. VivoSim Labs' average media sentiment score of 1.87 beat Bullfrog AI's score of 0.93 indicating that VivoSim Labs is being referred to more favorably in the news media.

Company	Overall Sentiment
Bullfrog AI	Positive
VivoSim Labs	Very Positive

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Bullfrog AI	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50
VivoSim Labs	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Bullfrog AI has a beta of -2.7, indicating that its share price is 370% less volatile than the broader market. Comparatively, VivoSim Labs has a beta of 1.47, indicating that its share price is 47% more volatile than the broader market.

Bullfrog AI has a net margin of 0.00% compared to VivoSim Labs' net margin of -11,016.07%. Bullfrog AI's return on equity of -150.36% beat VivoSim Labs' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Bullfrog AI	N/A	-150.36%	-127.98%
VivoSim Labs	-11,016.07%	-612.23%	-177.02%

Summary

Bullfrog AI beats VivoSim Labs on 8 of the 13 factors compared between the two stocks.

How does Bullfrog AI compare to iSpecimen?

Bullfrog AI (NASDAQ:BFRG) and iSpecimen (NASDAQ:ISPC) are both small-cap healthcare companies, but which is the better stock? We will contrast the two businesses based on the strength of their valuation, dividends, earnings, risk, profitability, analyst recommendations, institutional ownership and media sentiment.

In the previous week, Bullfrog AI and Bullfrog AI both had 1 articles in the media. iSpecimen's average media sentiment score of 1.89 beat Bullfrog AI's score of 0.93 indicating that iSpecimen is being referred to more favorably in the news media.

Company	Overall Sentiment
Bullfrog AI	Positive
iSpecimen	Very Positive

Bullfrog AI has a net margin of 0.00% compared to iSpecimen's net margin of -2,445.40%. Bullfrog AI's return on equity of -150.36% beat iSpecimen's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Bullfrog AI	N/A	-150.36%	-127.98%
iSpecimen	-2,445.40%	-524.39%	-140.42%

Bullfrog AI has a beta of -2.7, indicating that its share price is 370% less volatile than the broader market. Comparatively, iSpecimen has a beta of 1.66, indicating that its share price is 66% more volatile than the broader market.

Bullfrog AI has higher earnings, but lower revenue than iSpecimen. Bullfrog AI is trading at a lower price-to-earnings ratio than iSpecimen, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Bullfrog AI	$120K	82.67	-$6.50M	-$0.46	N/A
iSpecimen	$1.93M	2.01	-$10.49M	-$56.44	N/A

1.0% of Bullfrog AI shares are owned by institutional investors. Comparatively, 13.6% of iSpecimen shares are owned by institutional investors. 14.7% of Bullfrog AI shares are owned by company insiders. Comparatively, 12.2% of iSpecimen shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Bullfrog AI	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50
iSpecimen	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Summary

Bullfrog AI beats iSpecimen on 8 of the 13 factors compared between the two stocks.

How does Bullfrog AI compare to Telesis Bio?

Bullfrog AI (NASDAQ:BFRG) and Telesis Bio (NASDAQ:TBIO) are both small-cap healthcare companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, profitability, media sentiment, earnings, analyst recommendations, institutional ownership, risk and valuation.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Bullfrog AI	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50
Telesis Bio	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

1.0% of Bullfrog AI shares are held by institutional investors. Comparatively, 37.6% of Telesis Bio shares are held by institutional investors. 14.7% of Bullfrog AI shares are held by company insiders. Comparatively, 24.5% of Telesis Bio shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Bullfrog AI has higher earnings, but lower revenue than Telesis Bio. Bullfrog AI is trading at a lower price-to-earnings ratio than Telesis Bio, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Bullfrog AI	$120K	82.67	-$6.50M	-$0.46	N/A
Telesis Bio	$225.09M	0.00	-$47.72M	-$20.52	N/A

In the previous week, Bullfrog AI and Bullfrog AI both had 1 articles in the media. Bullfrog AI's average media sentiment score of 0.93 beat Telesis Bio's score of 0.00 indicating that Bullfrog AI is being referred to more favorably in the media.

Company	Overall Sentiment
Bullfrog AI	Positive
Telesis Bio	Neutral

Bullfrog AI has a beta of -2.7, suggesting that its share price is 370% less volatile than the broader market. Comparatively, Telesis Bio has a beta of 2.45, suggesting that its share price is 145% more volatile than the broader market.

Bullfrog AI has a net margin of 0.00% compared to Telesis Bio's net margin of -336.59%. Telesis Bio's return on equity of 0.00% beat Bullfrog AI's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Bullfrog AI	N/A	-150.36%	-127.98%
Telesis Bio	-336.59%	N/A	-61.89%

Summary

Telesis Bio beats Bullfrog AI on 7 of the 13 factors compared between the two stocks.

Get Bullfrog AI News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding BFRG and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

BFRG vs. The Competition

Export

Metric	Bullfrog AI	Life Sciences Tools & Services Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$10.01M	$10.11B	$7.20B	$12.89B
Dividend Yield	N/A	1.46%	2.54%	11.27%
P/E Ratio	-1.16	62.94	272.60	25.49
Price / Sales	82.67	115.05	627.57	97.10
Price / Cash	N/A	26.70	28.74	36.03
Price / Book	2.82	5.46	11.03	6.34
Net Income	-$6.50M	$56.67B	$3.47B	$349.45M
7 Day Performance	-7.76%	-1.69%	0.14%	-0.67%
1 Month Performance	-3.59%	8.25%	8.16%	4.48%
1 Year Performance	-55.78%	24.30%	24.14%	14.94%

Bullfrog AI Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
BFRG Bullfrog AI	1.2785 of 5 stars	$0.54 -0.9%	N/A	-55.8%	$10.01M	$120K	N/A	4
HBIO Harvard Bioscience	1.2446 of 5 stars	$7.63 +0.6%	$6.75 -11.5%	+63.8%	$34.71M	$86.55M	N/A	490	Positive News
BNGO Bionano Genomics	2.2863 of 5 stars	$1.24 -1.2%	$6.00 +385.8%	-67.6%	$14.56M	$28.51M	N/A	300
VIVS VivoSim Labs	0.3331 of 5 stars	$0.29 +0.5%	N/A	-88.1%	$4.86M	$112K	N/A	20	Gap Down
ISPC iSpecimen	0.9127 of 5 stars	$1.64 +2.2%	N/A	-94.6%	$4.12M	$1.93M	N/A	60

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:BFRG) was last updated on 9/1/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Bullfrog AI (BFRG) Competitors

BFRG vs. HBIO, BNGO, VIVS, ISPC, and TBIO

How does Bullfrog AI compare to Harvard Bioscience?

Summary

How does Bullfrog AI compare to Bionano Genomics?

Summary

How does Bullfrog AI compare to VivoSim Labs?

Summary

How does Bullfrog AI compare to iSpecimen?

Summary

How does Bullfrog AI compare to Telesis Bio?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

BFRG vs. The Competition

Bullfrog AI Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Bullfrog AI (BFRG) Competitors

BFRG vs. HBIO, BNGO, VIVS, ISPC, and TBIO

How does Bullfrog AI compare to Harvard Bioscience?

Does the media refer more to HBIO or BFRG?

Which has more volatility and risk, HBIO or BFRG?

Do analysts rate HBIO or BFRG?

Which has stronger earnings and valuation, HBIO or BFRG?

Is HBIO or BFRG more profitable?

Do insiders and institutionals have more ownership in HBIO or BFRG?

Summary

How does Bullfrog AI compare to Bionano Genomics?

Do institutionals & insiders have more ownership in BFRG or BNGO?

Does the media refer more to BFRG or BNGO?

Do analysts recommend BFRG or BNGO?

Which has more risk and volatility, BFRG or BNGO?

Which has higher earnings and valuation, BFRG or BNGO?

Is BFRG or BNGO more profitable?

Summary

How does Bullfrog AI compare to VivoSim Labs?

Which has stronger earnings and valuation, BFRG or VIVS?

Do insiders and institutionals have more ownership in BFRG or VIVS?

Does the media refer more to BFRG or VIVS?

Do analysts prefer BFRG or VIVS?

Which has more risk & volatility, BFRG or VIVS?

Is BFRG or VIVS more profitable?

Summary

How does Bullfrog AI compare to iSpecimen?

Does the media refer more to BFRG or ISPC?

Is BFRG or ISPC more profitable?

Which has more risk and volatility, BFRG or ISPC?

Which has preferable earnings and valuation, BFRG or ISPC?

Do institutionals and insiders believe in BFRG or ISPC?

Do analysts rate BFRG or ISPC?

Summary

How does Bullfrog AI compare to Telesis Bio?

Do analysts recommend BFRG or TBIO?

Do insiders & institutionals believe in BFRG or TBIO?

Which has preferable earnings and valuation, BFRG or TBIO?

Does the media favor BFRG or TBIO?

Which has more risk & volatility, BFRG or TBIO?

Is BFRG or TBIO more profitable?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

BFRG vs. The Competition

Bullfrog AI Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools